Cargando…

Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma

Renal cell carcinoma (RCC) can cause various paraneoplastic syndromes, including metabolic and hematologic disturbances. Paraneoplastic hypereosinophilia has been reported in a variety of hematologic and solid tumors. Hypereosinophilia due to RCC is very rare and is only available as case reports in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellez, Halil İbrahim, Bayram, Esra, Demirciler, Erkut, Semiz, Hüseyin Salih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310309/
https://www.ncbi.nlm.nih.gov/pubmed/37398833
http://dx.doi.org/10.7759/cureus.39726
_version_ 1785066511616966656
author Ellez, Halil İbrahim
Bayram, Esra
Demirciler, Erkut
Semiz, Hüseyin Salih
author_facet Ellez, Halil İbrahim
Bayram, Esra
Demirciler, Erkut
Semiz, Hüseyin Salih
author_sort Ellez, Halil İbrahim
collection PubMed
description Renal cell carcinoma (RCC) can cause various paraneoplastic syndromes, including metabolic and hematologic disturbances. Paraneoplastic hypereosinophilia has been reported in a variety of hematologic and solid tumors. Hypereosinophilia due to RCC is very rare and is only available as case reports in the literature. A 66-year-old male patient's thoracoabdominal computed tomography (CT) performed showed an increase in size in the right kidney and a heterogeneous contrasting solid mass of approximately 12 cm × 9 cm, which formed lobulations in its contours. The patient was diagnosed with clear-cell renal carcinoma as a result of a kidney biopsy. In the patient with stage cT4NxM0, the leukocyte count was 40.000/µl and the eosinophil count was 20% in biochemical tests. With these results, the patient was evaluated as having severe paraneoplastic hypereosinophilia due to RCC. The patient was started on sunitinib 50 mg for two weeks on/one week off. No symptoms were observed due to hypereosinophilia. In the evaluation made two weeks after the start of the treatment, it was observed that eosinophil levels decreased to normal rates. Paraneoplastic hypereosinophilia due to renal cell carcinoma may indicate poor prognosis and rapid disease progression. Myelosuppressive therapy is required for symptomatic patients.
format Online
Article
Text
id pubmed-10310309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103103092023-06-30 Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma Ellez, Halil İbrahim Bayram, Esra Demirciler, Erkut Semiz, Hüseyin Salih Cureus Oncology Renal cell carcinoma (RCC) can cause various paraneoplastic syndromes, including metabolic and hematologic disturbances. Paraneoplastic hypereosinophilia has been reported in a variety of hematologic and solid tumors. Hypereosinophilia due to RCC is very rare and is only available as case reports in the literature. A 66-year-old male patient's thoracoabdominal computed tomography (CT) performed showed an increase in size in the right kidney and a heterogeneous contrasting solid mass of approximately 12 cm × 9 cm, which formed lobulations in its contours. The patient was diagnosed with clear-cell renal carcinoma as a result of a kidney biopsy. In the patient with stage cT4NxM0, the leukocyte count was 40.000/µl and the eosinophil count was 20% in biochemical tests. With these results, the patient was evaluated as having severe paraneoplastic hypereosinophilia due to RCC. The patient was started on sunitinib 50 mg for two weeks on/one week off. No symptoms were observed due to hypereosinophilia. In the evaluation made two weeks after the start of the treatment, it was observed that eosinophil levels decreased to normal rates. Paraneoplastic hypereosinophilia due to renal cell carcinoma may indicate poor prognosis and rapid disease progression. Myelosuppressive therapy is required for symptomatic patients. Cureus 2023-05-30 /pmc/articles/PMC10310309/ /pubmed/37398833 http://dx.doi.org/10.7759/cureus.39726 Text en Copyright © 2023, Ellez et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Ellez, Halil İbrahim
Bayram, Esra
Demirciler, Erkut
Semiz, Hüseyin Salih
Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title_full Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title_fullStr Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title_full_unstemmed Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title_short Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
title_sort paraneoplastic hypereosinophilia in locally advanced clear cell renal carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310309/
https://www.ncbi.nlm.nih.gov/pubmed/37398833
http://dx.doi.org/10.7759/cureus.39726
work_keys_str_mv AT ellezhalilibrahim paraneoplastichypereosinophiliainlocallyadvancedclearcellrenalcarcinoma
AT bayramesra paraneoplastichypereosinophiliainlocallyadvancedclearcellrenalcarcinoma
AT demircilererkut paraneoplastichypereosinophiliainlocallyadvancedclearcellrenalcarcinoma
AT semizhuseyinsalih paraneoplastichypereosinophiliainlocallyadvancedclearcellrenalcarcinoma